A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

NCT01849289 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

833

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Degludec
DRUG: Insulin Glargine

Sponsor

Novo Nordisk A/S